Parya Saberi, PharmD

Headshot of Parya Saberi
User Profile Photo

Parya Saberi, PharmD

User Profile Name
Associate Professor, School of Medicine
CTSI Profile Title
User Profile Email


Parya Saberi, PharmD, MAS is an Assistant Professor at the Center for AIDS Prevention Studies in the Department of Medicine at the University of California, San Francisco. She is also an HIV Clinical Pharmacist at Ward 86 (Positive Health Program) at San Francisco General Hospital. Dr. Saberi's is funded by the National Institute of Mental Health through a K23 Mentored Patient-oriented Research Career Development Award. Her current area of research includes adapting technology-based strategies to improve antiretroviral adherence and engagement in HIV Care among HIV-positive youth. These methods include social networking technologies, video-conferencing tools, and text messaging. Additionally, she is involved in the development of an index of engagement in HIV care as well as research regarding retention and adherence to HIV care in South Africa.

User Profile Bio

Displaying 1 - 25 of 89

  1. Camp CE, Chan CT, Saberi P. Young Adult Perspectives on Sex, Dating, and PrEP Use During the Pandemic and Improving the Future of PrEP Care. AIDS Behav. 2023 Jan 11; 1-9.
  2. Dubé K, Campbell CK, Eskaf S, Sauceda JA, Ndukwe S, Henley L, Persaud D, Deeks SG, Auerbach JD, Saberi P. Willingness of Racially Diverse Young Adults Living with HIV to Participate in HIV Cure Research: A Cross-Sectional Survey in the United States. AIDS Res Hum Retroviruses. 2022 Nov 10.
  3. Saberi P, Stoner MCD, Eskaf S, Ndukwe S, Campbell CK, Sauceda JA, Dubé K. Preferences for HIV Treatment Formulations among Young Adults with HIV in the United States. J Acquir Immune Defic Syndr. 2022 Nov 07.
  4. Campbell CK, Ndukwe S, Dub? K, Sauceda JA, Saberi P. Overcoming Challenges of Online Research: Measures to Ensure Enrollment of Eligible Participants. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):232-236.
  5. Epstein A, Nagata JM, Ganson KT, Nash D, Saberi P, Tsai AC, Charlebois ED, Weiser SD. Drought, HIV Testing, and HIV Transmission Risk Behaviors: A Population-Based Study in 10 High HIV Prevalence Countries in Sub-Saharan Africa. AIDS Behav. 2022 Sep 06.
  6. Saberi P, Eskaf S, Campbell CK, Neilands TB, Sauceda JA, Dub? K. Exploration of a Mobile Technology Vulnerability Scale's association with antiretroviral adherence among young adults living with HIV in the United States. Mhealth. 2022; 8:23.
  7. Stoner MCD, Maragh-Bass AC, Sukhija-Cohen AC, Saberi P. Digital directly observed therapy to monitor adherence to medications: a scoping review. HIV Res Clin Pract. 2022 07 18; 23(1):47-60.
  8. Saberi P, Mehtani NJ, Sayegh A, Camp CE, Chu C. Understanding HIV Pre-Exposure Prophylaxis Questions of U.S. Health Care Providers: Unique Perspectives from the PrEPline Clinical Teleconsultation Service. Telemed J E Health. 2022 Jul 08.
  9. Saberi P, Campbell CK, Sauceda JA, Ndukwe S, Dubé K. Perceptions of Risks and Benefits of Participating in HIV Cure-Related Research Among Diverse Young Adults Living with HIV in the United States: Qualitative Research Findings. AIDS Res Hum Retroviruses. 2022 Aug; 38(8):649-659.
  10. Saberi P, Stoner MCD, Ming K, Lisha NE, Hojilla JC, Scott HM, Liu AY, Steward WT, Johnson MO, Neilands TB. The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions. AIDS. 2022 11 01; 36(13):1783-1789.
  11. Shrestha I, Ming K, Jimenez V, Wendelborn J, Vazquez A, Steward W, Scott H, Saberi P. Lessons Learned from an HIV Pre-Exposure Prophylaxis Coordination Program in San Francisco Primary Care Clinics. AIDS Res Hum Retroviruses. 2022 Aug; 38(8):611-614.
  12. Chan CT, Ming K, Camp C, Saberi P. Sexual Behaviors, Substance Use, and Quality of Life Among Individuals Using PrEP in San Francisco During the COVID-19 Pandemic Shelter-In-Place Orders: A Cross-Sectional Survey. J Acquir Immune Defic Syndr. 2022 04 01; 89(4):e39-e42.
  13. Hojilla JC, Gandhi M, Satre DD, Johnson MO, Saberi P. Equity in access to long-acting injectables in the USA. Lancet HIV. 2022 03; 9(3):e145-e147.
  14. Saberi P, Ming K, Shrestha I, Scott H, Thorson B, Liu A. Feasibility and Acceptability of Home-Collected Samples for Human Immunodeficiency Virus Preexposure Prophylaxis and Severe Acute Respiratory Syndrome Coronavirus 2 Laboratory Tests in San Francisco Primary Care Clinics. Open Forum Infect Dis. 2022 Feb; 9(2):ofab657.
  15. Miall A, McLellan R, Dong K, Ndung'u T, Saberi P, Sauceda JA, Dubé K. Bringing social context into global biomedical HIV cure-related research: An urgent call to action. J Virus Erad. 2022 Mar; 8(1):100062.
  16. Arnold EA, Saberi P, Wong JO, Pollack LM, Neilands TB, Benjamin M, Lockett G, Kegeles SM. We are Family: A Feasibility and Acceptability Study of an HIV Prevention Intervention With the House Ball and Gay Family Communities. J Acquir Immune Defic Syndr. 2021 12 15; 88(S1):S6-S11.
  17. Saberi P, Campbell CK, Lee EY, Guzman J, McCormack-Sharp MM, Dubé K. Illustrating HIV Cure Research Strategies for the Next Generation of Research Participants: A Research-Community Collaboration. AIDS Res Hum Retroviruses. 2022 01; 38(1):5-10.
  18. Campbell CK, Dubé K, Sauceda JA, Ndukwe S, Saberi P. Antiretroviral therapy experience, satisfaction, and preferences among a diverse sample of young adults living with HIV. AIDS Care. 2022 Sep; 34(9):1212-1218.
  19. Kim HC, Pollack LM, Saberi P, Neilands TB, Arnold EA, Bright DJ, Williams RW, Kegeles SM, Tan JY. Study protocol: a pilot randomised waitlist-controlled trial of a dyadic mobile health intervention for black sexual-minority male couples with HIV in the USA. BMJ Open. 2021 09 02; 11(9):e055448.
  20. Saberi P, Lisha NE, Erguera XA, Hudes ES, Johnson MO, Ruel T, Neilands TB. A Mobile Health App (WYZ) for Engagement in Care and Antiretroviral Therapy Adherence Among Youth and Young Adults Living With HIV: Single-Arm Pilot Intervention Study. JMIR Form Res. 2021 Aug 31; 5(8):e26861.
  21. Dubé K, Kanazawa J, Taylor J, Dee L, Jones N, Roebuck C, Sylla L, Louella M, Kosmyna J, Kelly D, Clanton O, Palm D, Campbell DM, Onaiwu MG, Patel H, Ndukwe S, Henley L, Johnson MO, Saberi P, Brown B, Sauceda JA, Sugarman J. Ethics of HIV cure research: an unfinished agenda. BMC Med Ethics. 2021 06 30; 22(1):83.
  22. Dubé K, Kanazawa J, Campbell C, Boone CA, Maragh-Bass AC, Campbell DM, Agosto-Rosario M, Stockman JK, Diallo DD, Poteat T, Johnson M, Saberi P, Sauceda JA. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry. AIDS Res Hum Retroviruses. 2021 May 31.
  23. Camp C, Saberi P. Facilitators and barriers of 2-1-1 HIV pre-exposure prophylaxis. PLoS One. 2021; 16(5):e0251917.
  24. Saberi P, Ming K, Hojilla JC, Scott HM, Neilands TB. HIV Preexposure Prophylaxis in the Time of COVID-19: How a Robust and Responsive HIV Preexposure Prophylaxis Intervention Can Avert Loss of HIV Prevention Coverage During a Global Pandemic. J Acquir Immune Defic Syndr. 2021 05 01; 87(1):e173-e176.
  25. Lisha NE, Neilands TB, Erguera XA, Saberi P. Development of the Mobile Technology Vulnerability Scale among Youth and Young Adults Living with HIV. Int J Environ Res Public Health. 2021 04 15; 18(8).